treatment rheumatoid arthriti monoclon antibodi clinic result immunopharmacolog effect open studi administr recent experiment clinic data point helper lymphocyt subset central role pathogenesi rheumatoid arthriti RA therapeut strategi cell subset patient activ RA day daili dose mg monoclon antibodi minut neg side effect chang combin paramet ritchi articular index pain assess grip strength morn stiff patient good respons clinic improv week termin therapi week month serolog paramet inflamm c-reactiv protein level patient favor respons close immunolog monitor transient select deplet cell infus entir treatment period residu circul cell antibodi free antibodi serum hour infus infus solubl antigen serum addit cell-bound antibodi complement compon surfac cell prolif respons peripher blood mononuclear cell protein deriv week cessat antibodi treatment patient weak antibodi respons immunoglobulin respond second cours therapi outpati therapeut effect similar first cours patient low titer serum ige anti-mous Ig antibodi mild anaphylact reaction end second cours therapi treatment RA monoclon antibodi promis altern optim dose regimen administr 